Literature DB >> 10540644

Mucinous versus nonmucinous rectal carcinomas: differentiation with MR imaging.

S M Hussain1, E K Outwater, E S Siegelman.   

Abstract

PURPOSE: To determine if quantitative and qualitative magnetic resonance (MR) imaging measures can help differentiation of mucinous from nonmucinous rectal tumors.
MATERIALS AND METHODS: In 26 patients with pathologically proved mucinous (n = 9) and nonmucinous (n = 17) rectal tumors, MR imaging was performed with T1-weighted spin-echo (SE) and T2-weighted fast SE sequences in all patients and with a gadolinium-enhanced T1-weighted sequence in 18. With use of the signal intensity (SI) measurements in the tumors and reference tissues, tumor-to-muscle, tumor-to-fat, and tumor-to-urine SI ratios were calculated. In addition, the SI and contrast-enhancement patterns in the tumors were assessed qualitatively by three blinded readers.
RESULTS: Mucinous tumors had a much higher SI on the T2-weighted fast SE images. Tumor-to-muscle, tumor-to-fat, and tumor-to-urine SI ratios were significantly higher in the mucinous compared with the nonmucinous tumors (P = .0004, P = .0008, and P = .00002, respectively). Qualitative evaluation of the SI correlated well between readers 1 and 2 (r = 0.93), readers 1 and 3 (r = 0.94), and readers 2 and 3 (r = 0.91). Agreement for the contrast-enhancement patterns was 67%, 72%, and 67%, respectively, with most mucinous tumors having predominantly high SI and a peripheral contrast-enhancement pattern.
CONCLUSION: Mucinous and nonmucinous rectal tumors can be differentiated with MR imaging because mucinous tumors show high SI on T2-weighted fast SE images.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540644     DOI: 10.1148/radiology.213.1.r99se3879

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  Diffusion-weighted imaging in rectal cancer: current applications and future perspectives.

Authors:  Niels W Schurink; Doenja M J Lambregts; Regina G H Beets-Tan
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

2.  Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.

Authors:  I Song; S H Kim; S J Lee; J Y Choi; M J Kim; H Rhim
Journal:  Br J Radiol       Date:  2011-02-22       Impact factor: 3.039

Review 3.  Magnetic resonance imaging in rectal cancer: a surgeon's perspective.

Authors:  Avanish P Saklani; Sung Uk Bae; Amy Clayton; Nam Kyu Kim
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

4.  Current trends in staging rectal cancer.

Authors:  Abdus Samee; Chelliah Ramachandran Selvasekar
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

5.  Diffusion-weighted imaging findings of mucinous carcinoma arising in the ano-rectal region: comparison of apparent diffusion coefficient with that of tubular adenocarcinoma.

Authors:  Katsuhiro Nasu; Yoshifumi Kuroki; Manabu Minami
Journal:  Jpn J Radiol       Date:  2011-12-16       Impact factor: 2.374

Review 6.  Mucinous carcinoma of the rectum: a distinct clinicopathological entity.

Authors:  M Chand; S Yu; R I Swift; G Brown
Journal:  Tech Coloproctol       Date:  2013-12-11       Impact factor: 3.781

7.  Magnetic resonance imaging of rectal cancer.

Authors:  Mai-Lan Ho; Judy Liu; Vamsidhar Narra
Journal:  Clin Colon Rectal Surg       Date:  2008-08

Review 8.  Advances in the care of patients with mucinous colorectal cancer.

Authors:  Niek Hugen; Gina Brown; Robert Glynne-Jones; Johannes H W de Wilt; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2015-09-01       Impact factor: 66.675

9.  Diffusion-weighted MRI in locally advanced rectal cancer : pathological response prediction after neo-adjuvant radiochemotherapy.

Authors:  M Intven; O Reerink; M E P Philippens
Journal:  Strahlenther Onkol       Date:  2012-12-19       Impact factor: 3.621

Review 10.  How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy?

Authors:  Paola De Nardi; Michele Carvello
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.